Viewing Study NCT01738893


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2025-12-27 @ 2:46 AM
Study NCT ID: NCT01738893
Status: COMPLETED
Last Update Posted: 2017-06-20
First Post: 2012-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of 300 mg Gabapentin
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module